Page 16 - Delaware Medical Journal - October 2017
P. 16
TABLE 2: Breast Cancer Cases Diagnosed in 2014 Who Did Not Receive Radiation Therapy, Delaware
VARIABLE
NUMBER
Age (mean ± sd)
55.6 ± 10.5
Radiation therapy was not administered; it was recommended by the patient’s physician but this treatment was refused by the patient, the patient’s family member, or the patient’s guardian.
3
Radiation therapy was recommended, but it is unknown if it was administered.
1
It is unknown if radiation therapy was recommended or administered.
6
Total
10
Source: Delaware Health and Social Services, Division of Public Health, Delaware Cancer Registry, 2017
everyone (97 percent) received radiation, the breakdown for those who received radiation by race was very similar to the overall population. For those who did not get radiation, reasons for not getting radiation were extracted from the DCR. The breakdown for those who did not get radiation is shown in Table 2.
DISCUSSION
In this study, Delaware Cancer Registry data were evaluated using the CP3R measure, BCSRT, which assesses whether radiation therapy was administered for selected breast cancer patients receiving breast conserving surgery. When the coded data in the Delaware Cancer Registry, supplemented with information from the DHIN and hospital cancer registries, was evaluated, it was found that 96 percent of patients received radiation therapy within 365 days. The CoC’s 2016 expected EPR (estimated performance difference was found when comparing the time to radiation in days for the White (mean=125 days) and Other (mean=161 days) groups.
interval from diagnosis to the beginning of radiation therapy. These include whether the patient receives chemotherapy, the desires
of the patient, other patient comorbidities, the stage of disease at diagnosis, and recommendations from the patient’s physician.
DCR data submitted annually to the CDC-NPCR and to NAACCR meet all quality criteria established by these standard setting organizations; however, remaining limitations of this study are database. A potential solution is to conduct a data quality review of a random sample of cases from the subset under evaluation to assess level of accuracy.
This journal article was supported by the cooperative agreement number U56/DP003870-05 from the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of CDC.
CONTRIBUTING AUTHORS
■ BETSYCROMARTIE,MA,CTRistheprojectmanagerfortheDelawareCancer Registry, Delaware Health and Social Services, Division of Public Health.
■ BOBHALL-MCBRIDE,CTRisthemanageroftheOncologyDataCenterat Christiana Care Health Services in Newark, Del.
■ ZEINABBABA,DrPH,MSistheepidemiologistfortheComprehensiveCancer Control Program, Delaware Health and Social Services, Delaware Division of Public Health.
REFERENCES
1.
2.
3.
4.
5.
American College of Surgeons (2016). Rapid Quality Report System User Guide. Available at: https://www.facs.org/~/media/files/ quality%20programs/cancer/ncdb/rqrs_userguide_2016.ashx. Accessed March 29, 2017.
American College of Surgeons (2016). Rapid Quality Reporting System. Available at: https://www.facs.org/quality-programs/ cancer/ncdb/qualitytools/rqrs. Accessed March 29, 2017.
American College of Surgeons (2016). Cancer Program Practice Profile Reports (CP3R). Available at: https://www.facs.org/quality- programs/cancer/ncdb/qualitytools/cp3r. Accessed March 29, 2016.
Cromartie B, Hall-McBride B, Baba Z. Commission on Cancer (CoC) CP3R Measures for Colon Cancer Evaluation of Delaware Cancer Registry Data. Del J Public Health, 2017:3;14-18.
American College of Surgeons (2016). CoC Quality of Care Measures. Available at: https://www.facs.org/quality-programs/ cancer/ncdb/qualitymeasures. Accessed March 29, 2017.
304
Del Med J | October 2017 | Vol. 89 | No. 10
